Cargando…
Mutagenicity and teratogenicity studies of vitacoxib in rats and mice
Vitacoxib is a new drug candidate for treatment of inflammation, pain and fever as selective cyclooxygenase-2 inhibitors. In the current study, the mice sperm abnormality, mammalian erythrocyte micronucleus and in vivo chromosome aberration, and teratogenicity in SD rats were evaluated. Vitacoxib di...
Autores principales: | Wang, Jianzhong, Sun, Feifei, Tang, Shusheng, Zhang, Suxia, Li, Jing, Cao, Xingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098211/ https://www.ncbi.nlm.nih.gov/pubmed/30128300 http://dx.doi.org/10.1016/j.toxrep.2018.08.007 |
Ejemplares similares
-
Evaluation of dermal irritation and skin sensitization due to vitacoxib
por: Wang, Jianzhong, et al.
Publicado: (2017) -
Pharmacokinetics, Tissue Distribution, Metabolism and Excretion of a Novel COX-2 Inhibitor, Vitacoxib, in Rats
por: Wang, Jianzhong, et al.
Publicado: (2022) -
Non-Linear Mixed-Effects Pharmacokinetic Modeling of the Novel COX-2 Selective Inhibitor Vitacoxib in Cats
por: Wang, Jianzhong, et al.
Publicado: (2020) -
Carcinogenic, teratogenic, and mutagenic effects of arsenic.
por: Bencko, V
Publicado: (1977) -
Teratogenicity, mutagenicity, and cellular toxicity of phthalate esters.
por: Dillingham, E O, et al.
Publicado: (1973)